CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net loss	$ (4,003)	$ (3,911)
Depreciation and amortization	813	667
Stock-based compensation expense	538	606
Fair value loss on convertible note, net	30	0
Inventory LCNRV write-downs and losses on firm purchase commitments	14	114
Other non-cash activities	85	46
Changes in operating assets and liabilities:
Accounts receivable, net	(57)	(135)
Inventory	(208)	(1,471)
Other assets	(41)	(129)
Accounts payable and accrued liabilities	(339)	220
Other liabilities	269	234
Net cash used in operating activities	(2,899)	(3,759)
Cash flows from investing activities:
Purchases of short-term investments	(2,476)	(1,405)
Maturities of short-term investments	2,696	225
Capital expenditures	(814)	(728)
Net cash used in investing activities	(594)	(1,908)
Cash flows from financing activities:
Proceeds from issuance of capital stock including employee stock purchase plan	37	39
Proceeds from issuance of convertible notes	1,000	1,485
Other financing activities	(5)	(15)
Net cash provided by financing activities	1,032	1,509
Effect of exchange rate changes on cash and cash equivalents	0	0
Net change in cash	(2,461)	(4,158)
Cash, cash equivalents, and restricted cash—Beginning of period	7,857	12,099
Cash, cash equivalents, and restricted cash—End of period	5,396	7,941
Supplemental disclosure of non-cash investing and financing activities:
Capital expenditures included in liabilities	369	390
Capital stock issued to settle bonuses	179	137
Right-of-use assets obtained in exchange for operating lease liabilities	$ 122	$ 66